Your Notifications
All done, no notifications
Dr. Yi Hyeon Gyu

Dr. Yi Hyeon Gyu

Hemato Oncologist

, Ho Chi Minh, Vietnam

26 Years of experience

Speaks: English, Vietnamese

Dr. Yi Hyeon Gyu is currently not consulting online with MediGence
View Telemedicine Doctors

About Dr. Yi Hyeon Gyu

  • With more than 26 years of experience in clinical, research, and academic roles in the field of hematology and oncology, Prof. Yi Hyeon Gyu is a distinguished Hematologist and Oncologist.
  • He is the Head of the Oncology and Hematology Department at Vinmec Times City International Hospital, as well as the Director of Year 3 of the MD Program at VinUniversity College of Health Sciences.
  • Prof. Yi specializes in hematopoietic stem cell transplantation, medical oncology, and advanced cell therapy. He has also made significant contributions to medical education and clinical research in both South Korea and Vietnam.

Conditions treated by Dr. Yi Hyeon Gyu

  • Benign and malignant hematologic diseases
  • Leukemia, lymphoma, and myeloma
  • Hematopoietic stem cell transplantation cases
  • Blood disorders and coagulopathies
  • Patients requiring cell therapies, including AIET (autologous immune enhancement therapy)

Area of Interest

  • Hematology and medical oncology
  • Stem cell transplantation and cell-based therapies
  • Clinical research and molecular genetic studies
  • Medical education and faculty training in clinical trials
  • Hospice-palliative care and anti-smoking initiatives

Qualification

  • M.D: Inha University College of Medicine, South Korea (1994–1999)
  • M.S. Pharmacology: Inha University Graduate School (1999–2001)
  • Ph.D. Pharmacology: Inha University Graduate School (2001–2010)
  • B.D: Counselling Psychology, Seoul Cyber University (2015–2017)

Work Experiences

  • Resident, Department of Internal Medicine: Inha University Hospital, South Korea (2003–2006)
  • Clinical Instructor: Seoul National University Hospital (2007–2008)
  • Faculty positions at Inha University School of Medicine, advancing from Instructor to Associate Professor (2008–2017)
  • Oncology Department: Vinmec Times City International Hospital (2017–2019)
  • Global Team of Board Certified Surgeons and Medical Specialists
  • Written Second Opinion report delivered within 5 days
  • Option to avail the Video Consultation with the Lead Doctor of the board

Access Our most trusted Medical Second Opinion

Required | alphabets and spaces
Required | A valid, working email address
Required | A valid contact

Telemedicine Doctors

CERTIFICATIONS (3)

  • Specialist training in Hematology and Oncology
  • Advanced experience in hematopoietic stem cell transplantation
  • Expertise in autologous immune enhancement therapy (AIET)

MEMBERSHIPS (8)

  • The Korean Cancer Association
  • The Korean Cancer Study Group
  • The Korean Society of Hematology
  • Korean Blood and Marrow Transplant Registry
  • KoNECT Faculty Education Program (clinical trial training)
  • Institutional Review Board, Inha University Hospital
  • Regional Anti-Smoking Support Centre, South Korea
  • Hospice-Palliative Care Centre, Inha University Hospital

RESEARCH PAPERS AND PUBLICATIONS (5)

  • Jung KS, Kim YJ, Kim YK, Park SK, Kim HG, Kim SJ, Park J, Choi CW, Do YR, Kim I, Park S, Mun YC, Jeong SH, Kim MK, Yi HG, Chang MH, Kim SY, Lee JH, Jang JH. Clinical Outcomes of Decitabine Treatment for Patients With Lower-Risk Myelodysplastic Syndrome Based on the International Prognostic Scoring System. Clin Lymphoma Myeloma Leuk. 2019 Jun 27. pii: S2152-2650(19)30234-4
  • Choi JY, Yi HG, Park CS, Shin DW, Kang JH. Inhibition of oxaliplatin-induced neurotoxicity by silymarin through increased expression of brain-derived neurotrophic factor and inhibition of p38-MAPK, Molecular & Cellular Toxicology 2019;15(2), 145–152
  • Lee GW, Park SW, Go SI, Kim HG, Kim MK, Min CK, Kwak JY, Bae SB, Yoon SS, Lee JJ, Kim KH, Nam SH, Mun YC, Kim HJ, Bae SH, Shin HJ, Lee JH, Park JS, Jeong SH, Lee MH, Lee HS, Park KW, Lee WS, Lee SM, Lee JO, Hyun MS, Jo DY, Lim SN, Lee JH, Kim H, Cho DY, Do YR, Kim JA, Park SK, Kim JS, Kim SJ, Yi HG, Moon JH, Choi CW, Kim SH, Kim BS, Park MR, Shim H, Song MK, Kim Y, Kim K. The Derived Neutrophil-to-Lymphocyte Ratio Is an Independent Prognostic Factor in Patients with Multiple Myeloma. Acta Haematol. 2018;140(3):146-156.
  • Kim WH, Bae JN, Lim J, Lee MH, Hahm BJ, Yi HG. Relationship between physicians' perceived stigma toward depression and physician referral to psycho-oncology services on an oncology/hematology ward. Psychooncology. 2018 Mar;27(3):824-830.
  • Kim MK, Kim K, Min CK, Kwak JY, Bae SB, Yoon SS, Lee JJ, Kim KH, Nam SH, Mun YC, Kim HJ, Bae SH, Shin HJ, Lee JH, Park JS, Jeong SH, Lee MH, Kim YS, Lee HS, Park KW, Lee WS, Lee SM, Lee JO, Hyun MS, Jo DY, Lim SN, Lee JH, Cho DY, Do YR, Kim JA, Park SK, Kim JS, Kim SJ, Kim H, Yi HG, Moon JH, Choi CW, Kim SH, Joo YD, Kim HG, Kim BS, Park MR, Song MK, Kim SY. A prospective, open-label, multicenter, observational study to evaluate the efficacy and safety of bortezomib-melphalan-prednisone as initial treatment for autologous stem cell transplantation-ineligible patients with multiple myeloma. Oncotarget. 2017 Apr 3. doi: 10.18632/oncotarget.. 16790.

Share Your Experience about Dr. Yi Hyeon Gyu

Write Your Review

PROCEDURES

  • Adrenal Cancer Treatment
  • Bone Marrow Transplant
  • Breast Cancer Treatment
  • Cervical Cancer Treatment
  • Lung Cancer Treatment
  • Stem Cell Therapy

FREQUENTLY ASKED QUESTIONS

Who is a Hemato-Oncologist?

A Hemato-Oncologist is a physician who diagnoses and treats diseases involving blood, bone marrow, and lymphatic systems, as well as types of cancers, including leukemia, lymphoma, and myeloma. They treat both benign and malignant blood disorders with medical therapies, chemotherapy, and advanced cell therapies.

What does a Hemato-Oncologist treat?

A Hemato-Oncologist treats conditions such as anemia, hemophilia, clotting disorders, leukemia, lymphoma, multiple myeloma, myelodysplastic syndromes, bone marrow failure, and other cancers of the blood and lymphatic systems.

What are the symptoms that may require an appointment with a Hemato-Oncologist?

You should see a Hemato-Oncologist if you have fatigue that cannot be explained, frequent infections, bleeding that is prolonged or difficult to stop, unexplained weight loss, fever that cannot be accounted for, and/or swollen lymph nodes, as these symptoms could be indicative of blood or oncological conditions requiring further evaluation.

What tests do Hemato-Oncologist recommend?

Common diagnostic testing recommendations may include a complete blood count (CBC) with or without a peripheral blood smear, as well as a bone marrow biopsy. You may also be recommended for genetic and/or molecular tests, flow cytometry, and imaging tests such as CT, MRI, or PET scans to help diagnose, evaluate, and/or stage hematologic cancers.

What treatment options can a hemato oncologist provide?

Treatment options available include chemotherapy, immunotherapy, targeted therapy, hormonal therapy, blood transfusions, stem cell/bone marrow transplantation, and palliative care to alleviate symptoms and maximise quality of life.